BACARDI-LIMITED
30.3.2021 13:02:15 CEST | Business Wire | Press release
After decades spent carefully building sustainable partnerships with farmers and suppliers, BOMBAY SAPPHIRE, the iconic premium gin from family-owned Bacardi Limited, is proud to announce that all 10 of its botanical ingredients are on track to be certified sustainable in 2021. With the suppliers of eight already certified according to the For Life standard, the goal is for the remaining two producers – for grains of paradise from Ghana and liquorice from China – to be certified in the months which follow the lifting of travel restrictions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210330005556/en/
This news is a major step towards Bacardi, the largest privately-held spirits company in the world, achieving its 2025 goal of sourcing 100% of its key ingredients from sustainably certified suppliers.
The 10 botanicals, which include juniper from Tuscany, coriander from Morocco, lemon peel from Spain and cubeb berries from Java, are hand selected by BOMBAY SAPPHIRE Master of Botanicals Ivano Tonutti to create the gin’s fresh, bright taste.
Only the finest quality botanicals are selected by Ivano and his work does not end there. The For Life certification awarded by Ecocert S.A., the world’s leading specialist in the certification of sustainable practices, recognizes the commitment of Ivano and Bacardi to only work with suppliers who act responsibly and ensure a sustainable future for farmers, their communities and the environment.
BOMBAY SAPPHIRE has pioneered sustainability in the spirits industry. The brand has long invested in new innovations offering creative solutions to complex challenges. When the BOMBAY SAPPHIRE distillery opened in Laverstoke, England, in 2014 it set a new standard for sustainability by showcasing many such innovations – the distillery’s design was rated ‘outstanding’ by BREEAM , the most recognized environmental assessment for buildings.
“We take a 360-degree approach to sustainability,” says Ivano Tonutti. ”It’s our responsibility to care as much about the farmers and their communities as we do the botanicals they grow and harvest for BOMBAY SAPPHIRE. By looking after their well-being and investing in sustainable farming practices, we are helping to protect the environment and their livelihoods for generations to come.”
An example of this in practice is the village in Ghana where, over a number of years, Bacardi has worked with AIESEC, a local non-governmental organization, to help the community establish itself as an independent farming cooperative – from installing a water pump, which now supplies the village with fresh water, to recruiting an agronomist for expert advice and guidance. This year, the village will harvest its first crop of grains of paradise for BOMBAY SAPPHIRE.
“For Life certification gives consumers peace of mind that ingredients are coming from organizations committed to continuous improvement,” says Ecocert CEO Philippe Thomazo. “For Life means that suppliers growing and harvesting the certified botanicals for BOMBAY SAPPHIRE are acting responsibly in every respect.”
Natasha Curtin, VP BOMBAY SAPPHIRE, says: “I am incredibly proud of this latest achievement by Ivano and his team but as an industry, we must all invest in a more sustainable future. Ivano has spent more than 20 years building close relationships with our farmers and suppliers around the world. With his experience and expertise, we have created a blueprint for the sustainable sourcing of botanicals, which we hope will inspire others to do the same.”
Bacardi worked closely with its suppliers to help them achieve For Life certification. To be certified, suppliers must commit to continuous improvement in the following areas:
- the well-being of the people involved in the harvesting and supply of the botanicals;
- the reduction of their environmental impact;
- their responsible purchasing practices;
- and sustainable development at a local level and key stages in the supply chain.
Find out more about the sustainability commitments of Bacardi and its vision to become the most environmentally responsible global spirits company at https://www.bacardilimited.com/corporate-responsibility/environment/ .
Always drink responsibly.
About BOMBAY SAPPHIRE gin
BOMBAY SAPPHIRE, the world's number one premium gin, is created with a unique combination of 10 botanical ingredients sourced from around the globe. In the historic still houses of the BOMBAY SAPPHIRE distillery in Hampshire, England, spirit vapour passes through perforated copper baskets filled by hand with the 10 botanicals. Through this signature distillation process, called vapour infusion
, BOMBAY SAPPHIRE perfectly captures the natural, aromatic flavors of each botanical which results in the gin's fresh, bright taste. Awarded a double gold medal in the 2017 San Francisco World Spirits Competition, BOMBAY SAPPHIRE is consistently recognized for crafting the finest quality gin. For more information, please explore www.bombaysapphire.com
.
BOMBAY SAPPHIRE is part of the portfolio of Bacardi Limited, with global headquarters in Hamilton, Bermuda. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited.
About Bacardi Limited
Bacardi Limited, the largest privately held spirits company in the world, produces and markets internationally recognized spirits and wines. The Bacardi Limited brand portfolio comprises more than 200 brands and labels, including BACARDÍ® rum, GREY GOOSE® vodka, PATRÓN® tequila, DEWAR’S® Blended Scotch whisky, BOMBAY SAPPHIRE® gin, MARTINI® vermouth and sparkling wines, CAZADORES® 100% blue agave tequila, and other leading and emerging brands including WILLIAM LAWSON’S® Scotch whisky, ST-GERMAIN® elderflower liqueur, and ERISTOFF® vodka. Founded nearly 160 years ago in Santiago de Cuba, family-owned Bacardi Limited currently employs more than 7,000, operates production facilities in 11 countries, and sells its brands in more than 170 countries. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited. Visit www.bacardilimited.com
or follow us on Twitter
, LinkedIn
or Instagram
.
About Ecocert Group
With over 30 years of commitment to sustainability and to the development of organic farming worldwide, Ecocert provides stakeholders with support in understanding, implementing and promoting sustainable practices through training, consulting and independent certification services. Ecocert only offers a range of selected, recognized, and demanding standards with high environmental and societal criteria. For organizations willing to go further in the transition, Ecocert also develops innovative programs with higher requirements (Fair For Life, For Life, En Cuisine, etc.). Today the group is also a world leading company in the certification of organic agriculture and cosmetic, present in more than 130 countries through an international network of 31 subsidiaries with over 1,700 collaborators. To find out more on how Ecocert acts for a sustainable world, please visit: www.ecocert.com
or follow Ecocert on LinkedIn
or Facebook
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210330005556/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
